Figure 4 | Leukemia

Figure 4

From: Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts

Figure 4

Mouse and human SF3B1-K700E share aberrant splicing properties, but affect different mRNA transcripts. (a) Comparison of consensus sequences upstream of aberrant and canonical 3′ ss shows a striking preservation of these motifs between mouse Sf3b1K700E/+ lin cells and several human SF3B1-mutant cancers. (b) Distribution of distances of aberrant 3′ss (AG) from the downstream canonical AG is also strikingly similar between mouse Sf3b1K700E/+ lin cells and human cancer samples. (c) By contrast, a comparison of genes found to be aberrantly spliced in human vs mouse samples shows minimal overlap. (d) Poor sequence preservation in the mouse of the aberrant splice sites affecting human genes TMEM14C and ABCB7 that are thought to trigger the formation of ring sideroblasts in MDS. (e) Volcano plots comparing mRNA expression between Sf3b1K700E/+ vs Sf3b1+/+ BM and lin cells. The mRNA expression of genes Slc25a37, Tmem14c, Alas2 and Abcb7, thought to be involved in the formation of ring sideroblasts, is not significantly altered by the K700E mutation in mice. The number of aberrant events used to generate images in a and b is indicated in b (brackets). BRCA, breast cancer; CLL, chronic lymphocytic leukemia; MDS, myelodysplastic syndromes; SKCM, skin cutaneous melanoma.

Back to article page